Citadel Advisors
MDWD icon

Citadel Advisors’s MediWound MDWD Stock Holding History

Citadel Advisors’s Portfolio MDWD Stock Details MDWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$860K Sell
58,496
-744
-1% -$11.8K ﹤0.01% 8592
2026
Q1 		$954K Sell
59,240
-30,398
-34% -$529K ﹤0.01% 7760
2025
Q4 		$1.65M Buy
+89,638
New +$1.64M ﹤0.01% 6303
2025
Q3 		– Sell
-32,059
Closed -$621K – 13566
2025
Q2 		$621K Buy
32,059
+27,493
+602% +$518K ﹤0.01% 8124
2025
Q1 		$70.9K Buy
+4,566
New +$81.7K ﹤0.01% 11897
2024
Q4 		– Sell
-23
Closed -$415 – 15040
2024
Q3 		$415 Sell
23
-13,608
-100% -$248K ﹤0.01% 14022
2024
Q2 		$212K Sell
13,631
-13,556
-50% -$224K ﹤0.01% 9809
2024
Q1 		$387K Buy
27,187
+10,489
+63% +$144K ﹤0.01% 8923
2023
Q4 		$170K Buy
+16,698
New +$150K ﹤0.01% 10202
2021
Q2 		– Sell
-2,381
Closed -$90K – 14092
2021
Q1 		$90K Buy
+2,381
New +$86.3K ﹤0.01% 12562
2020
Q3 		– Sell
-1,781
Closed -$37K – 10468
2020
Q2 		$37K Buy
+1,781
New +$25.4K ﹤0.01% 9413
2020
Q1 		– Sell
-2,560
Closed -$55K – 9934
2019
Q4 		$55K Buy
+2,560
New +$53.1K ﹤0.01% 8730
2018
Q1 		– Sell
-2,194
Closed -$68K – 8575
2017
Q4 		$68K Buy
+2,194
New +$73.9K ﹤0.01% 7546
2016
Q4 		– Sell
-4,803
Closed -$259K – 7608
2016
Q3 		$259K Buy
4,803
+208
+5% +$11.1K ﹤0.01% 5918
2016
Q2 		$252K Hold
4,595
– – ﹤0.01% 5474
2016
Q1 		$260K Sell
4,595
-447
-9% -$23.4K ﹤0.01% 5288
2015
Q4 		$302K Buy
5,042
+447
+10% +$28.2K ﹤0.01% 5202
2015
Q3 		$245K Sell
4,595
-370
-7% -$18.2K ﹤0.01% 5859
2015
Q2 		$245K Sell
4,965
-7,040
-59% -$306K ﹤0.01% 6043
2015
Q1 		$609K Sell
12,005
-24
-0.2% -$1.28K ﹤0.01% 4626
2014
Q4 		$561K Sell
12,029
-46,285
-79% -$1.9M ﹤0.01% 4570
2014
Q3 		$2.56M Sell
58,314
-18,957
-25% -$1.09M ﹤0.01% 2592
2014
Q2 		$6.16M Sell
77,271
-3,902
-5% -$318K 0.01% 1664
2014
Q1 		$8.19M Buy
+81,173
New +$9.19M 0.01% 1397

Other funds holding MDWD

IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
YLHM
Yelin Lapidot Holdings Management Tel Aviv, Israel $527M AUM 50.16% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
SBCM
Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Citadel Advisors's MDWD Position: Q2 2026 in Review

Citadel Advisors reduced its MediWound (MDWD) stake by 1.3% in Q2 2026, selling an estimated $11.8K and leaving 58,496 shares worth $860K. The position accounts for ﹤0.01% of the portfolio, ranked #8592.

Citadel Advisors first reported a position in MDWD in Q1 2014 and has held it in 24 quarters since. The position peaked at $8.19M in Q1 2014. 79 funds tracked by Wall St. Rank hold MDWD as of Q2 2026.

  • Citadel Advisors held 58,496 shares of MediWound worth $860K as of Q2 2026.
  • Citadel Advisors sold 744 MediWound shares in Q2 2026, an estimated $11.8K.
  • MediWound made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #8592 holding.
  • Citadel Advisors first reported a position in MediWound in Q1 2014 and has held it in 24 quarters since.
  • Citadel Advisors's MediWound position peaked at $8.19M in Q1 2014.
  • 79 funds tracked by Wall St. Rank held MediWound as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.